SCHEDULE: Earlyworks Investor Exits 5% Stake, Strategic Acquisition Looms

Sentiment:

Beneficial Ownership Update 18 November 2025 7:42 PM

North York Ltd. and Ashwood Leon Forbes have filed an amendment indicating they no longer beneficially own more than 5% of Earlyworks Co., Ltd.'s outstanding shares, while the company pursues a significant acquisition.

Capital raiseThe issuer sold and issued Pre-Funded Warrants and Warrants to several investors, including North York, for a total purchase price of $5,000,001.76 in an initial closing on October 14, 2025.A second closing of the Offering occurred on November 17, 2025, though North York assigned its participation rights to a third-party investor.A subsequent acquisition transaction by the end of 2025 may involve the issuance of $3,000,000 of restricted Ordinary Shares.

Worse than expectedA significant investor (North York) has reduced its beneficial ownership below the 5% threshold, indicating a potential divestment or lack of further commitment.North York assigned its rights to participate in a second closing of the Offering to a third-party, suggesting they are not increasing their stake.An option to purchase 1,000,000 ADSs from the CEO expired unexercised, which could be seen as a missed opportunity or a decision not to increase direct ownership.

Summary

North York Ltd. and Ashwood Leon Forbes (Reporting Persons) have filed an Amendment No. 1 to their Schedule 13D, indicating they have ceased to be beneficial owners of more than 5% of Earlyworks Co., Ltd.'s outstanding Ordinary Shares and American Depositary Shares (ADSs).
This filing constitutes an 'exit filing' for the Reporting Persons.
As of November 14, 2025, their aggregate beneficial ownership is 801,091 Ordinary Shares, representing 4.9% of the class.
This ownership consists of Ordinary Shares issuable upon exercise of certain Warrants and Pre-Funded Warrants, which are subject to a 4.99% beneficial ownership limitation.
Previously, North York purchased Pre-Funded Warrants and Warrants for $3,000,000 in an initial closing on October 14, 2025.
North York also held an option to purchase 1,000,000 ADSs (representing 5,000,000 Ordinary Shares) from the CEO for $100, which expired unexercised on November 14, 2025.
North York assigned its right to participate in a second closing of the Offering to a third-party investor on November 15, 2025.
The issuer was required to include two North York-designated nominees for election to the board at a shareholder meeting held on November 14, 2025.
The issuer is obligated to use Offering funds to acquire a third-party entity ('Target') by issuing 19.99% of outstanding Ordinary Shares and additional securities upon achievement of certain milestones.
Definitive documentation for the Acquisition is required by November 30, 2025.

Sentiment

Score: 4

Explanation: The filing indicates an investor reducing its stake below a key threshold and assigning away rights to further participation, which is generally a negative signal. While the company is pursuing an acquisition, the investor's reduced commitment and the expiration of an option suggest a less favorable outlook from this specific investor's perspective.

Positives

The issuer successfully completed an initial closing of an Offering, raising $5,000,001.76, with North York contributing $3,000,000.
The issuer held a Shareholder Meeting on November 14, 2025, and recommended the election of two North York-designated nominees to the Board, ensuring continued representation.
The issuer is actively pursuing an acquisition of a third-party entity, which could expand its business and strategic direction.

Negatives

A significant investor (North York) has reduced its beneficial ownership below the 5% threshold, indicating a potential decrease in conviction or a strategic divestment.
North York assigned its rights to participate in the second closing of the Offering to a third-party, suggesting they are not increasing their stake further.
An option to purchase 1,000,000 ADSs from the CEO expired unexercised on November 14, 2025, which could be interpreted as a decision not to increase direct ownership.

Risks

The Acquisition of the Target entity might not occur by November 30, 2025, which would require the issuer to consult with nominees on alternative fund usage.
The issuer's ability to comply with applicable Japanese laws regarding the Second Closing could impact future transactions and capital raises.
The Reporting Persons may acquire additional securities, retain, or sell existing holdings in the open market or privately, which could introduce volatility to the share price.
The Reporting Persons may engage in discussions to explore extraordinary corporate transactions, such as mergers, reorganizations, asset sales, or changes to capitalization or management, which could be disruptive.

Future Outlook

The Reporting Persons intend to continue reviewing their investments in the issuer. The issuer is required to use funds from the Offering to consummate an acquisition of a third-party entity by issuing 19.99% of outstanding Ordinary Shares and additional securities upon milestones. A merger with the Target and a subsequent acquisition transaction, potentially involving $3,000,000 of restricted Ordinary Shares, is intended by the end of 2025. Definitive documentation for the Acquisition is due by November 30, 2025. If the Acquisition does not occur, the issuer must consult with the nominated directors on the use of Offering funds. The Reporting Persons may also explore extraordinary corporate transactions, including mergers, asset sales, or changes to capitalization or management.

Management Comments

The issuer was required to include two individuals designated by North York as nominees for election to the board of directors of the issuer in its proxy statement.
The Board was required to recommend to the shareholders of the issuer the election of such Nominees at such Shareholder Meeting.
The issuer is required to use reasonable best efforts to use the funds obtained from the Offering to consummate the Acquisition of all of the equity interests of a third party entity.
The issuer and the Investors, including North York, intend for the issuer to merge with the Target and then consummate a subsequent acquisition transaction by the end of 2025.
In the event that an Acquisition does not occur by November 30, 2025, the issuer must consult with the Nominees to determine how such Offering funds will be used.

Industry Context

This filing primarily concerns a change in beneficial ownership by a specific investor group and outlines the issuer's strategic plans for an acquisition. It doesn't provide broad industry trends but indicates Earlyworks Co., Ltd. is actively pursuing M&A to potentially expand its business or strategic direction. The involvement of an investment holding company like North York suggests a focus on strategic investments and potential corporate restructuring.

Comparison to Industry Standards

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Board of Directors	NA	Two individuals designated by North York	2025-11-14	Election at Shareholder Meeting as per Purchase Agreements.
Replacement Director	Current director (if vacancy occurs)	Nominee designated by North York	Within 30 days of vacancy	Right to nominate a replacement director in case of vacancy.
Board members and executive officers	NA	Individuals designated by the Target	Prior to and upon shareholder approval of the Acquisition	Right granted to the Target in connection with the Acquisition.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Composition	The issuer was required to include two North York-designated individuals as nominees for election to the board of directors and recommend their election at the Shareholder Meeting.	2025-11-14	Increases North York's influence on the Board, even after reducing its beneficial ownership below 5%.
Board Appointment Rights	North York was granted the right to nominate a replacement director if a current director ceases to serve, requiring the Board to appoint such nominee within 30 days.	Ongoing from Initial Closing	Ensures continued representation and influence for North York on the Board.
Board and Executive Officer Designation Rights	The Target entity will be granted the right to designate additional Board members and executive officers of the issuer prior to and upon shareholder approval of the Acquisition.	Prior to and upon shareholder approval of the Acquisition	Significant shift in corporate control and management structure upon successful acquisition.

Related Party Transactions

North York entered into an Option Agreement with the Chief Executive Officer (CEO) of Earlyworks Co., Ltd. to purchase ADSs beneficially owned by the CEO.

Stakeholder Impact

Shareholders: The reduction in beneficial ownership by a key investor (North York) could be perceived negatively, potentially impacting share price. The planned acquisition and potential merger could significantly alter the company's structure and future prospects, requiring shareholder approval for certain aspects.
Management/Board: The addition of North York-designated nominees to the board and the future designation rights for the Target entity's representatives will change the composition and potentially the strategic direction of the Board and executive management.
Employees: The planned acquisition and merger could lead to integration challenges, potential restructuring, or changes in corporate culture.
Creditors: The acquisition and any subsequent capital raises could alter the company's financial leverage and risk profile.

Next Steps

The issuer is required to enter into definitive documentation for the Acquisition by November 30, 2025.
If the Acquisition does not occur by November 30, 2025, the issuer must consult with the North York-designated nominees to determine how the Offering funds will be used.
The issuer and investors intend to merge with the Target and consummate a subsequent acquisition transaction by the end of 2025.
Reporting Persons may acquire additional securities, retain or sell existing holdings, or engage in discussions regarding extraordinary corporate transactions.

Key Dates

Date	Description
2025-10-10	Date North York and the CEO entered into an Option Agreement.
2025-10-14	Date of the initial closing of the Offering where North York purchased warrants.
2025-11-14	Date of the issuer's 2025 annual meeting of shareholders and expiration of the Option.
2025-11-14	Date Reporting Persons ceased to be beneficial owners of more than five percent of outstanding shares.
2025-11-15	Date North York assigned its rights to participate in the second closing of the Offering to a third-party investor.
2025-11-17	Date of the second closing of the Offering.
2025-11-18	Date of filing this Amendment No. 1.
2025-11-30	Deadline for the issuer to enter into definitive documentation for the Acquisition.
2025-12-31	Target date for the issuer to merge with the Target and consummate a subsequent acquisition transaction.
2030-10-09	Expiration date for Warrants purchased in the Offering.

Recommendation

hold

While the exit filing by a significant investor and the expiration of an option could be seen as negative signals, the company is actively pursuing a strategic acquisition and has secured new board representation for the exiting investor. This indicates ongoing strategic developments that could reshape the company. The situation is complex, with both potential downsides (investor reducing stake) and upsides (strategic acquisition, new board members). A 'hold' recommendation allows investors to observe the outcome of the planned acquisition and its integration before making a definitive buy or sell decision. The 4.9% remaining beneficial ownership and board representation suggest continued, albeit reduced, influence from North York.

Keywords

Earlyworks Co. Ltd., Schedule 13D/A, Beneficial Ownership, North York Ltd., Ashwood Leon Forbes, Warrants, Pre-Funded Warrants, American Depositary Shares, Ordinary Shares, SEC Filing, Investment Holding, Corporate Governance, Acquisition, Exit Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.